Rubicon Research Limited (RUBICON) — Financial Results
Rubicon Research Limited announced that its trading window will close on July 1, 2026, ahead of the unaudited financial results for the quarter and year ending June 30, 2026, and will reopen 48 hours after results are submitted to exchanges.
About Rubicon Research Limited (RUBICON)
Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE
📡 Get AI alerts when RUBICON files next
Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions
Track RUBICON — Free💡 Ask AI about this filing
📊 More RUBICON filings
- Announcement — 20 July 2026 Rubicon Research Limited announced on July 20, 2026, that its Nomination and Remuneration Committee ...
- Announcement — 3 July 2026 Rubicon Research Limited disclosed that the US FDA conducted an unannounced inspection of its newly ...
- 🔴 Announcement — 19 June 2026 No summary available
- 🔴 Announcement — 10 June 2026 No summary available
- 🔴 Financial Results — 2 June 2026 Rubicon Research reported Q4 FY26 revenue of **₹5,139 crores**, up 44% YoY, with PAT rising 112% to ...
🔥 Also filed on 29 June 2026
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.
📡 Get AI alerts when RUBICON files new disclosures
Track RUBICON filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track RUBICON — FreeFree account · 2 AI queries/day
© 2026 StockFin.ai — AI-powered Indian stock research